Pectolinarigenin Suppresses E2F1-Dependent RRM2 Transcription Through ROS Accumulation to Inhibit Glioblastoma Progression
Current Issues in Molecular Biology · 19.11.2026 · 48 (11) · 1255
DOI: 10.3390/cimb48111255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 19.11.2026. Verfasst von Haiping Jiang und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Scientific Research Project of Guangdong Provincial Administration of Traditional Chinese Medicine, Collaborative Traditional Chinese and Western Medicine Specialty Cultivation Project, Affliated Hospital of Guangdong Medical University.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) exhibits marked dependence on ribonucleotide reductase regulatory subunit M2 (RRM2) to cope with endogenous replication stress. Pectolinarigenin (PECT) suppresses GBM partly by inhibiting RRM2, yet the upstream mechanism conveying PECT’s effect to the RRM2 promoter remains undefined.
Methods
Bioinformatic prediction (PROMO, SwissRegulon, JASPAR, TFsearch) and TCGA/GTEx analyses (GEPIA2) were used to identify and characterize candidate regulators of RRM2. U251 and U87 GBM cells were analyzed by DCFH-DA staining, MTT assay, qRT-PCR, and Western blotting with siRNA knockdown, overexpression, NAC rescue, and dual-luciferase reporter assays using wild-type and binding-site-mutant RRM2 promoter reporters.
Results
PECT-induced ROS accumulation and ROS-dependent cytotoxicity in GBM cells. E2F1 was upregulated in GBM, correlated with RRM2 expression (R = 0.71), and predicted poor overall survival (HR = 1.5, log-rank p = 0.028); E2F1 knockdown reduced RRM2 at both mRNA and protein levels. PECT dose-dependently suppressed E2F1 and RRM2, with E2F1 mRNA declining prior to RRM2, and NAC reversed PECT-mediated E2F1 suppression, demonstrating ROS dependence. A predicted GC-rich E2F1-response element (5′-CGGGCGCGAGA−3′) in the RRM2 promoter was required for E2F1-mediated transactivation and for PECT-induced repression, and ectopic E2F1 partially rescued GBM cells from PECT-induced cytotoxicity.
Conclusions
Taken together, our data support a model in which PECT suppresses RRM2 transcription through ROS-dependent downregulation of its upstream activator E2F1, identifying the ROS–E2F1–RRM2 axis as a candidate for therapeutic targeting in GBM.
Förderung
- the Scientific Research Project of Guangdong Provincial Administration of Traditional Chinese Medicine
- Collaborative Traditional Chinese and Western Medicine Specialty Cultivation Project
- Affliated Hospital of Guangdong Medical University
Zitieren
APA
Jiang, H., Chen, F., Liu, W., Zhao, S., & Xiao, J. (2026). Pectolinarigenin Suppresses E2F1-Dependent RRM2 Transcription Through ROS Accumulation to Inhibit Glioblastoma Progression. Current Issues in Molecular Biology, 48(11), 1255. https://doi.org/10.3390/cimb48111255
Vancouver
Jiang H, Chen F, Liu W, Zhao S, Xiao J. Pectolinarigenin Suppresses E2F1-Dependent RRM2 Transcription Through ROS Accumulation to Inhibit Glioblastoma Progression. Current Issues in Molecular Biology. 2026;48(11):1255. doi:10.3390/cimb48111255
BibTeX
@article{Jiang2026,
author = {Jiang, Haiping and Chen, Feng and Liu, Wenwu and Zhao, Shiguang and Xiao, Jianqi},
title = {Pectolinarigenin Suppresses E2F1-Dependent RRM2 Transcription Through ROS Accumulation to Inhibit Glioblastoma Progression},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {11},
pages = {1255},
doi = {10.3390/cimb48111255}
}
EUVIMED